Invitae is offering a Spark-sponsored genetic testing program at no charge* for individuals suspected of having inherited retinal disease (IRD). This program gives patients access to a broad genetic testing panel of approximately 250 genes associated with IRDs.
IRDs are a group of rare eye disorders caused by an inherited gene mutation and can result in vision loss or blindness. Common IRDs include retinitis pigmentosa, choroideremia, Leber congenital amaurosis, cone-rod dystrophy, and juvenile macular degeneration.
*This initiative is open to U.S. residents only, subject to the Terms and Conditions of the program.
Estimate your out-of-pocket cost for Invitae tests related to a personal or family history of breast, ovarian, colorectal, or uterine cancer.
The amount shown above is an estimate of your out-of-pocket cost based upon the information you entered about your health insurance coverage. It is not a confirmation that the test has been authorized by your insurance provider. Your final cost may vary based upon your health plan design, deductible, co-insurance, and out-of-pocket limits. Learn More >
As part of Invitae’s dedication to making high-quality genetic testing affordable and accessible, we also offer a patient pre-pay option of $250. Learn More >
We could not determine an out-of-pocket estimate. Please contact us for assistance.